nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—GSR—Oxidative Stress—NOX4—atherosclerosis	0.0311	0.0846	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—CYBA—atherosclerosis	0.0123	0.0335	CbGpPWpGaD
Carmustine—GSR—Glutathione metabolism—GSTM1—atherosclerosis	0.0109	0.0297	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—SOD1—atherosclerosis	0.0107	0.0291	CbGpPWpGaD
Carmustine—GSR—Glutathione metabolism—GPX1—atherosclerosis	0.0104	0.0284	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—SOD1—atherosclerosis	0.00983	0.0268	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—SOD2—atherosclerosis	0.00963	0.0262	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—HMOX1—atherosclerosis	0.00947	0.0258	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—GPX1—atherosclerosis	0.00919	0.025	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—SOD2—atherosclerosis	0.00885	0.0241	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—GPX1—atherosclerosis	0.00845	0.023	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—ALOX5AP—atherosclerosis	0.00791	0.0215	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—ALOX5—atherosclerosis	0.00673	0.0183	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—MPO—atherosclerosis	0.00596	0.0162	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—LDLR—atherosclerosis	0.00592	0.0161	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—F7—atherosclerosis	0.00572	0.0156	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—SCARB1—atherosclerosis	0.00554	0.0151	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—CYP7A1—atherosclerosis	0.00521	0.0142	CbGpPWpGaD
Carmustine—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00516	0.00816	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—PLAT—atherosclerosis	0.0051	0.0139	CbGpPWpGaD
Carmustine—Drug interaction—Simvastatin—atherosclerosis	0.00493	0.00779	CcSEcCtD
Carmustine—Neck pain—Ezetimibe—atherosclerosis	0.00485	0.00767	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—CYP27A1—atherosclerosis	0.00482	0.0131	CbGpPWpGaD
Carmustine—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.00481	0.00761	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—ABCA1—atherosclerosis	0.00466	0.0127	CbGpPWpGaD
Carmustine—Injury—Rosuvastatin—atherosclerosis	0.00455	0.0072	CcSEcCtD
Carmustine—Amnesia—Rosuvastatin—atherosclerosis	0.00446	0.00705	CcSEcCtD
Carmustine—Drug interaction—Pravastatin—atherosclerosis	0.00446	0.00704	CcSEcCtD
Carmustine—Gynaecomastia—Lovastatin—atherosclerosis	0.00437	0.00691	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—PLG—atherosclerosis	0.00434	0.0118	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—NFKB1—atherosclerosis	0.00432	0.0117	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—SOD1—atherosclerosis	0.00416	0.0113	CbGpPWpGaD
Carmustine—Gynaecomastia—Simvastatin—atherosclerosis	0.00409	0.00647	CcSEcCtD
Carmustine—Skin exfoliation—Niacin—atherosclerosis	0.00401	0.00634	CcSEcCtD
Carmustine—GSR—Nucleotide metabolism—GPX1—atherosclerosis	0.00393	0.0107	CbGpPWpGaD
Carmustine—Neuropathy—Pravastatin—atherosclerosis	0.00388	0.00614	CcSEcCtD
Carmustine—Injury—Lovastatin—atherosclerosis	0.00386	0.0061	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—APOB—atherosclerosis	0.00383	0.0104	CbGpPWpGaD
Carmustine—Diabetes mellitus—Simvastatin—atherosclerosis	0.00382	0.00603	CcSEcCtD
Carmustine—Amnesia—Lovastatin—atherosclerosis	0.00378	0.00597	CcSEcCtD
Carmustine—Swelling—Simvastatin—atherosclerosis	0.00376	0.00595	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—SOD2—atherosclerosis	0.00374	0.0102	CbGpPWpGaD
Carmustine—Amnesia—Ezetimibe—atherosclerosis	0.0037	0.00586	CcSEcCtD
Carmustine—Gynaecomastia—Pravastatin—atherosclerosis	0.0037	0.00585	CcSEcCtD
Carmustine—Muscular weakness—Rosuvastatin—atherosclerosis	0.00369	0.00584	CcSEcCtD
Carmustine—Abnormal vision—Niacin—atherosclerosis	0.00366	0.00579	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—GPX1—atherosclerosis	0.00357	0.00972	CbGpPWpGaD
Carmustine—Amnesia—Simvastatin—atherosclerosis	0.00353	0.00558	CcSEcCtD
Carmustine—Diabetes mellitus—Niacin—atherosclerosis	0.0035	0.00554	CcSEcCtD
Carmustine—CYP1A2—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.00348	0.00946	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—MTHFR—atherosclerosis	0.0033	0.00897	CbGpPWpGaD
Carmustine—Injury—Pravastatin—atherosclerosis	0.00326	0.00516	CcSEcCtD
Carmustine—Depression—Rosuvastatin—atherosclerosis	0.00322	0.00509	CcSEcCtD
Carmustine—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00321	0.00508	CcSEcCtD
Carmustine—Amnesia—Pravastatin—atherosclerosis	0.00319	0.00505	CcSEcCtD
Carmustine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00316	0.005	CcSEcCtD
Carmustine—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00314	0.00496	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—CRP—atherosclerosis	0.00314	0.00853	CbGpPWpGaD
Carmustine—Muscular weakness—Ezetimibe—atherosclerosis	0.00307	0.00485	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00305	0.00482	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—APOA1—atherosclerosis	0.00303	0.00825	CbGpPWpGaD
Carmustine—Diplopia—Pravastatin—atherosclerosis	0.003	0.00474	CcSEcCtD
Carmustine—Face oedema—Niacin—atherosclerosis	0.00294	0.00465	CcSEcCtD
Carmustine—Muscular weakness—Simvastatin—atherosclerosis	0.00293	0.00463	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—F2—atherosclerosis	0.00289	0.00787	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—ICAM1—atherosclerosis	0.00288	0.00784	CbGpPWpGaD
Carmustine—Liver function test abnormal—Niacin—atherosclerosis	0.00281	0.00445	CcSEcCtD
Carmustine—Liver function test abnormal—Pravastatin—atherosclerosis	0.00277	0.00438	CcSEcCtD
Carmustine—Muscular weakness—Niacin—atherosclerosis	0.00269	0.00425	CcSEcCtD
Carmustine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00268	0.00424	CcSEcCtD
Carmustine—GSR—NRF2 pathway—HMOX1—atherosclerosis	0.00267	0.00726	CbGpPWpGaD
Carmustine—Urinary tract infection—Lovastatin—atherosclerosis	0.00266	0.0042	CcSEcCtD
Carmustine—Muscular weakness—Pravastatin—atherosclerosis	0.00265	0.00418	CcSEcCtD
Carmustine—Dysphagia—Niacin—atherosclerosis	0.00263	0.00416	CcSEcCtD
Carmustine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00263	0.00416	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.00262	0.00714	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—INS—atherosclerosis	0.00262	0.00713	CbGpPWpGaD
Carmustine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00259	0.00409	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—CCL2—atherosclerosis	0.00258	0.00702	CbGpPWpGaD
Carmustine—Depression—Simvastatin—atherosclerosis	0.00255	0.00403	CcSEcCtD
Carmustine—Mental disorder—Rosuvastatin—atherosclerosis	0.00254	0.00401	CcSEcCtD
Carmustine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00251	0.00396	CcSEcCtD
Carmustine—GSR—NRF2 pathway—GSTM1—atherosclerosis	0.00249	0.00677	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—LTA4H—atherosclerosis	0.00244	0.00663	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.00241	0.00655	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—ALB—atherosclerosis	0.0024	0.00654	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—AGER—atherosclerosis	0.0024	0.00653	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.00238	0.00647	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—HSPA1B—atherosclerosis	0.00238	0.00646	CbGpPWpGaD
Carmustine—Oedema peripheral—Ezetimibe—atherosclerosis	0.00237	0.00375	CcSEcCtD
Carmustine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00237	0.00374	CcSEcCtD
Carmustine—Depression—Pravastatin—atherosclerosis	0.00231	0.00365	CcSEcCtD
Carmustine—Stomatitis—Niacin—atherosclerosis	0.00229	0.00362	CcSEcCtD
Carmustine—Flushing—Lovastatin—atherosclerosis	0.00228	0.0036	CcSEcCtD
Carmustine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00227	0.00358	CcSEcCtD
Carmustine—Urinary tract infection—Pravastatin—atherosclerosis	0.00225	0.00355	CcSEcCtD
Carmustine—Flushing—Ezetimibe—atherosclerosis	0.00223	0.00353	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—IFNG—atherosclerosis	0.00219	0.00597	CbGpPWpGaD
Carmustine—Alopecia—Lovastatin—atherosclerosis	0.00217	0.00343	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—GSTM1—atherosclerosis	0.00215	0.00585	CbGpPWpGaD
Carmustine—Myalgia—Rosuvastatin—atherosclerosis	0.00215	0.00339	CcSEcCtD
Carmustine—GSR—NRF2 pathway—PDGFB—atherosclerosis	0.00214	0.00582	CbGpPWpGaD
Carmustine—Flushing—Simvastatin—atherosclerosis	0.00213	0.00337	CcSEcCtD
Carmustine—Alopecia—Ezetimibe—atherosclerosis	0.00213	0.00336	CcSEcCtD
Carmustine—Haemoglobin—Niacin—atherosclerosis	0.00212	0.00335	CcSEcCtD
Carmustine—Mental disorder—Ezetimibe—atherosclerosis	0.00211	0.00333	CcSEcCtD
Carmustine—Haemorrhage—Niacin—atherosclerosis	0.00211	0.00333	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—PTGS2—atherosclerosis	0.0021	0.00572	CbGpPWpGaD
Carmustine—Hypoaesthesia—Niacin—atherosclerosis	0.0021	0.00332	CcSEcCtD
Carmustine—Erythema—Ezetimibe—atherosclerosis	0.0021	0.00331	CcSEcCtD
Carmustine—Malnutrition—Ezetimibe—atherosclerosis	0.0021	0.00331	CcSEcCtD
Carmustine—Oedema peripheral—Niacin—atherosclerosis	0.00208	0.00328	CcSEcCtD
Carmustine—Confusional state—Rosuvastatin—atherosclerosis	0.00207	0.00328	CcSEcCtD
Carmustine—Back pain—Lovastatin—atherosclerosis	0.00207	0.00327	CcSEcCtD
Carmustine—Hypoaesthesia—Pravastatin—atherosclerosis	0.00207	0.00327	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.00206	0.0056	CbGpPWpGaD
Carmustine—Infection—Rosuvastatin—atherosclerosis	0.00204	0.00323	CcSEcCtD
Carmustine—Visual impairment—Niacin—atherosclerosis	0.00203	0.00321	CcSEcCtD
Carmustine—Alopecia—Simvastatin—atherosclerosis	0.00203	0.00321	CcSEcCtD
Carmustine—Back pain—Ezetimibe—atherosclerosis	0.00203	0.00321	CcSEcCtD
Carmustine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00201	0.00319	CcSEcCtD
Carmustine—Vision blurred—Lovastatin—atherosclerosis	0.00201	0.00318	CcSEcCtD
Carmustine—Mental disorder—Simvastatin—atherosclerosis	0.00201	0.00318	CcSEcCtD
Carmustine—Tremor—Lovastatin—atherosclerosis	0.002	0.00317	CcSEcCtD
Carmustine—Visual impairment—Pravastatin—atherosclerosis	0.002	0.00316	CcSEcCtD
Carmustine—Erythema—Simvastatin—atherosclerosis	0.002	0.00316	CcSEcCtD
Carmustine—Eye disorder—Niacin—atherosclerosis	0.00197	0.00311	CcSEcCtD
Carmustine—Flushing—Niacin—atherosclerosis	0.00196	0.00309	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—IL1B—atherosclerosis	0.00196	0.00532	CbGpPWpGaD
Carmustine—Anaemia—Ezetimibe—atherosclerosis	0.00194	0.00306	CcSEcCtD
Carmustine—Flushing—Pravastatin—atherosclerosis	0.00193	0.00305	CcSEcCtD
Carmustine—Leukopenia—Lovastatin—atherosclerosis	0.00191	0.00302	CcSEcCtD
Carmustine—Vision blurred—Simvastatin—atherosclerosis	0.00188	0.00298	CcSEcCtD
Carmustine—Arrhythmia—Niacin—atherosclerosis	0.00188	0.00298	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00187	0.00296	CcSEcCtD
Carmustine—Tremor—Simvastatin—atherosclerosis	0.00187	0.00296	CcSEcCtD
Carmustine—Alopecia—Niacin—atherosclerosis	0.00186	0.00295	CcSEcCtD
Carmustine—Insomnia—Rosuvastatin—atherosclerosis	0.00186	0.00294	CcSEcCtD
Carmustine—Arrhythmia—Pravastatin—atherosclerosis	0.00185	0.00293	CcSEcCtD
Carmustine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00185	0.00292	CcSEcCtD
Carmustine—Anaemia—Simvastatin—atherosclerosis	0.00185	0.00292	CcSEcCtD
Carmustine—CYP1A2—Estrogen Receptor Pathway—PPARA—atherosclerosis	0.00184	0.005	CbGpPWpGaD
Carmustine—Malnutrition—Niacin—atherosclerosis	0.00184	0.0029	CcSEcCtD
Carmustine—Erythema—Niacin—atherosclerosis	0.00184	0.0029	CcSEcCtD
Carmustine—Alopecia—Pravastatin—atherosclerosis	0.00183	0.0029	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.00182	0.00496	CbGpPWpGaD
Carmustine—Chest pain—Lovastatin—atherosclerosis	0.00182	0.00288	CcSEcCtD
Carmustine—Myalgia—Lovastatin—atherosclerosis	0.00182	0.00288	CcSEcCtD
Carmustine—Anxiety—Lovastatin—atherosclerosis	0.00181	0.00287	CcSEcCtD
Carmustine—Hypertension—Ezetimibe—atherosclerosis	0.00181	0.00286	CcSEcCtD
Carmustine—Leukopenia—Simvastatin—atherosclerosis	0.00179	0.00283	CcSEcCtD
Carmustine—Chest pain—Ezetimibe—atherosclerosis	0.00178	0.00282	CcSEcCtD
Carmustine—Myalgia—Ezetimibe—atherosclerosis	0.00178	0.00282	CcSEcCtD
Carmustine—Pain—Rosuvastatin—atherosclerosis	0.00176	0.00278	CcSEcCtD
Carmustine—Constipation—Rosuvastatin—atherosclerosis	0.00176	0.00278	CcSEcCtD
Carmustine—Confusional state—Lovastatin—atherosclerosis	0.00176	0.00278	CcSEcCtD
Carmustine—Infection—Lovastatin—atherosclerosis	0.00173	0.00274	CcSEcCtD
Carmustine—Vision blurred—Niacin—atherosclerosis	0.00173	0.00273	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—SOD1—atherosclerosis	0.00173	0.0047	CbGpPWpGaD
Carmustine—Confusional state—Ezetimibe—atherosclerosis	0.00172	0.00273	CcSEcCtD
Carmustine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00171	0.0027	CcSEcCtD
Carmustine—Vision blurred—Pravastatin—atherosclerosis	0.0017	0.00269	CcSEcCtD
Carmustine—Myalgia—Simvastatin—atherosclerosis	0.0017	0.00269	CcSEcCtD
Carmustine—Chest pain—Simvastatin—atherosclerosis	0.0017	0.00269	CcSEcCtD
Carmustine—Infection—Ezetimibe—atherosclerosis	0.0017	0.00269	CcSEcCtD
Carmustine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.0017	0.00268	CcSEcCtD
Carmustine—Anxiety—Simvastatin—atherosclerosis	0.0017	0.00268	CcSEcCtD
Carmustine—Tremor—Pravastatin—atherosclerosis	0.00169	0.00268	CcSEcCtD
Carmustine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00168	0.00266	CcSEcCtD
Carmustine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00167	0.00265	CcSEcCtD
Carmustine—Anaemia—Pravastatin—atherosclerosis	0.00167	0.00264	CcSEcCtD
Carmustine—CYP1A2—Estrogen Receptor Pathway—ESR1—atherosclerosis	0.00166	0.00453	CbGpPWpGaD
Carmustine—Anorexia—Lovastatin—atherosclerosis	0.00166	0.00263	CcSEcCtD
Carmustine—Confusional state—Simvastatin—atherosclerosis	0.00164	0.0026	CcSEcCtD
Carmustine—Leukopenia—Niacin—atherosclerosis	0.00164	0.0026	CcSEcCtD
Carmustine—CYP1A2—Estrogen metabolism—GSTM1—atherosclerosis	0.00163	0.00444	CbGpPWpGaD
Carmustine—Oedema—Simvastatin—atherosclerosis	0.00163	0.00258	CcSEcCtD
Carmustine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00163	0.00257	CcSEcCtD
Carmustine—Infection—Simvastatin—atherosclerosis	0.00162	0.00256	CcSEcCtD
Carmustine—Leukopenia—Pravastatin—atherosclerosis	0.00162	0.00256	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—SIRT1—atherosclerosis	0.00162	0.00439	CbGpPWpGaD
Carmustine—Thrombocytopenia—Simvastatin—atherosclerosis	0.0016	0.00253	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00159	0.00251	CcSEcCtD
Carmustine—Insomnia—Lovastatin—atherosclerosis	0.00158	0.00249	CcSEcCtD
Carmustine—Paraesthesia—Lovastatin—atherosclerosis	0.00157	0.00248	CcSEcCtD
Carmustine—Myalgia—Niacin—atherosclerosis	0.00156	0.00247	CcSEcCtD
Carmustine—Hypertension—Pravastatin—atherosclerosis	0.00156	0.00247	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00156	0.00246	CcSEcCtD
Carmustine—Anorexia—Simvastatin—atherosclerosis	0.00155	0.00246	CcSEcCtD
Carmustine—Dyspnoea—Lovastatin—atherosclerosis	0.00155	0.00246	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—SOD2—atherosclerosis	0.00155	0.00423	CbGpPWpGaD
Carmustine—Insomnia—Ezetimibe—atherosclerosis	0.00155	0.00245	CcSEcCtD
Carmustine—GSR—Metabolism—LDLRAP1—atherosclerosis	0.00155	0.00421	CbGpPWpGaD
Carmustine—Myalgia—Pravastatin—atherosclerosis	0.00154	0.00243	CcSEcCtD
Carmustine—Chest pain—Pravastatin—atherosclerosis	0.00154	0.00243	CcSEcCtD
Carmustine—Paraesthesia—Ezetimibe—atherosclerosis	0.00154	0.00243	CcSEcCtD
Carmustine—Anxiety—Pravastatin—atherosclerosis	0.00153	0.00242	CcSEcCtD
Carmustine—CYP1A2—Arachidonic acid metabolism—ALOX5AP—atherosclerosis	0.00153	0.00417	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—ALOX15—atherosclerosis	0.00153	0.00417	CbGpPWpGaD
Carmustine—Dyspnoea—Ezetimibe—atherosclerosis	0.00152	0.00241	CcSEcCtD
Carmustine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00152	0.0024	CcSEcCtD
Carmustine—Decreased appetite—Lovastatin—atherosclerosis	0.00152	0.0024	CcSEcCtD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.00151	0.00411	CbGpPWpGaD
Carmustine—Oedema—Niacin—atherosclerosis	0.0015	0.00237	CcSEcCtD
Carmustine—Pain—Lovastatin—atherosclerosis	0.00149	0.00236	CcSEcCtD
Carmustine—Constipation—Lovastatin—atherosclerosis	0.00149	0.00236	CcSEcCtD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.00149	0.00405	CbGpPWpGaD
Carmustine—Confusional state—Pravastatin—atherosclerosis	0.00149	0.00235	CcSEcCtD
Carmustine—Decreased appetite—Ezetimibe—atherosclerosis	0.00149	0.00235	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00149	0.00235	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—GPX1—atherosclerosis	0.00148	0.00403	CbGpPWpGaD
Carmustine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00148	0.00233	CcSEcCtD
Carmustine—Asthenia—Rosuvastatin—atherosclerosis	0.00148	0.00233	CcSEcCtD
Carmustine—Insomnia—Simvastatin—atherosclerosis	0.00148	0.00233	CcSEcCtD
Carmustine—Oedema—Pravastatin—atherosclerosis	0.00147	0.00233	CcSEcCtD
Carmustine—Infection—Pravastatin—atherosclerosis	0.00146	0.00232	CcSEcCtD
Carmustine—Paraesthesia—Simvastatin—atherosclerosis	0.00146	0.00232	CcSEcCtD
Carmustine—Constipation—Ezetimibe—atherosclerosis	0.00146	0.00231	CcSEcCtD
Carmustine—Pain—Ezetimibe—atherosclerosis	0.00146	0.00231	CcSEcCtD
Carmustine—Tachycardia—Niacin—atherosclerosis	0.00146	0.00231	CcSEcCtD
Carmustine—GSR—Metabolism—PLTP—atherosclerosis	0.00145	0.00396	CbGpPWpGaD
Carmustine—Dyspnoea—Simvastatin—atherosclerosis	0.00145	0.0023	CcSEcCtD
Carmustine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00144	0.00228	CcSEcCtD
Carmustine—Feeling abnormal—Lovastatin—atherosclerosis	0.00144	0.00227	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—atherosclerosis	0.00143	0.00389	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—AHR—atherosclerosis	0.00143	0.00389	CbGpPWpGaD
Carmustine—Anorexia—Niacin—atherosclerosis	0.00143	0.00226	CcSEcCtD
Carmustine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00143	0.00225	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—TNF—atherosclerosis	0.00142	0.00386	CbGpPWpGaD
Carmustine—Decreased appetite—Simvastatin—atherosclerosis	0.00142	0.00224	CcSEcCtD
Carmustine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00141	0.00223	CcSEcCtD
Carmustine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00141	0.00223	CcSEcCtD
Carmustine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00141	0.00223	CcSEcCtD
Carmustine—Anorexia—Pravastatin—atherosclerosis	0.00141	0.00222	CcSEcCtD
Carmustine—Hypotension—Niacin—atherosclerosis	0.0014	0.00221	CcSEcCtD
Carmustine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.0014	0.00221	CcSEcCtD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.0014	0.0038	CbGpPWpGaD
Carmustine—Constipation—Simvastatin—atherosclerosis	0.00139	0.00221	CcSEcCtD
Carmustine—Pain—Simvastatin—atherosclerosis	0.00139	0.00221	CcSEcCtD
Carmustine—Body temperature increased—Lovastatin—atherosclerosis	0.00138	0.00218	CcSEcCtD
Carmustine—Abdominal pain—Lovastatin—atherosclerosis	0.00138	0.00218	CcSEcCtD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.00138	0.00375	CbGpPWpGaD
Carmustine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00136	0.00216	CcSEcCtD
Carmustine—Dizziness—Rosuvastatin—atherosclerosis	0.00136	0.00215	CcSEcCtD
Carmustine—Insomnia—Niacin—atherosclerosis	0.00135	0.00214	CcSEcCtD
Carmustine—Abdominal pain—Ezetimibe—atherosclerosis	0.00135	0.00214	CcSEcCtD
Carmustine—Body temperature increased—Ezetimibe—atherosclerosis	0.00135	0.00214	CcSEcCtD
Carmustine—Paraesthesia—Niacin—atherosclerosis	0.00134	0.00213	CcSEcCtD
Carmustine—Feeling abnormal—Simvastatin—atherosclerosis	0.00134	0.00213	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00134	0.00212	CcSEcCtD
Carmustine—Dyspnoea—Niacin—atherosclerosis	0.00134	0.00211	CcSEcCtD
Carmustine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00133	0.00211	CcSEcCtD
Carmustine—Insomnia—Pravastatin—atherosclerosis	0.00133	0.00211	CcSEcCtD
Carmustine—Somnolence—Niacin—atherosclerosis	0.00133	0.00211	CcSEcCtD
Carmustine—Paraesthesia—Pravastatin—atherosclerosis	0.00132	0.00209	CcSEcCtD
Carmustine—Dyspnoea—Pravastatin—atherosclerosis	0.00131	0.00208	CcSEcCtD
Carmustine—CYP1A2—Arachidonic acid metabolism—ALOX5—atherosclerosis	0.0013	0.00354	CbGpPWpGaD
Carmustine—Decreased appetite—Niacin—atherosclerosis	0.0013	0.00206	CcSEcCtD
Carmustine—Rash—Rosuvastatin—atherosclerosis	0.0013	0.00205	CcSEcCtD
Carmustine—Dermatitis—Rosuvastatin—atherosclerosis	0.0013	0.00205	CcSEcCtD
Carmustine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00129	0.00204	CcSEcCtD
Carmustine—Body temperature increased—Simvastatin—atherosclerosis	0.00129	0.00204	CcSEcCtD
Carmustine—Abdominal pain—Simvastatin—atherosclerosis	0.00129	0.00204	CcSEcCtD
Carmustine—Headache—Rosuvastatin—atherosclerosis	0.00129	0.00204	CcSEcCtD
Carmustine—Hypersensitivity—Lovastatin—atherosclerosis	0.00128	0.00203	CcSEcCtD
Carmustine—Decreased appetite—Pravastatin—atherosclerosis	0.00128	0.00203	CcSEcCtD
Carmustine—Pain—Niacin—atherosclerosis	0.00128	0.00203	CcSEcCtD
Carmustine—Constipation—Pravastatin—atherosclerosis	0.00126	0.00199	CcSEcCtD
Carmustine—Pain—Pravastatin—atherosclerosis	0.00126	0.00199	CcSEcCtD
Carmustine—GSR—Metabolism—LTA4H—atherosclerosis	0.00126	0.00343	CbGpPWpGaD
Carmustine—GSR—Metabolism—ABCG8—atherosclerosis	0.00126	0.00343	CbGpPWpGaD
Carmustine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00126	0.00199	CcSEcCtD
Carmustine—Asthenia—Lovastatin—atherosclerosis	0.00125	0.00198	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.00123	0.00334	CbGpPWpGaD
Carmustine—Asthenia—Ezetimibe—atherosclerosis	0.00123	0.00194	CcSEcCtD
Carmustine—Gastrointestinal pain—Niacin—atherosclerosis	0.00122	0.00194	CcSEcCtD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.00122	0.00333	CbGpPWpGaD
Carmustine—Nausea—Rosuvastatin—atherosclerosis	0.00122	0.00193	CcSEcCtD
Carmustine—Feeling abnormal—Pravastatin—atherosclerosis	0.00122	0.00192	CcSEcCtD
Carmustine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00121	0.00191	CcSEcCtD
Carmustine—Hypersensitivity—Simvastatin—atherosclerosis	0.0012	0.0019	CcSEcCtD
Carmustine—Diarrhoea—Lovastatin—atherosclerosis	0.00119	0.00189	CcSEcCtD
Carmustine—Body temperature increased—Niacin—atherosclerosis	0.00118	0.00187	CcSEcCtD
Carmustine—Abdominal pain—Niacin—atherosclerosis	0.00118	0.00187	CcSEcCtD
Carmustine—Asthenia—Simvastatin—atherosclerosis	0.00117	0.00185	CcSEcCtD
Carmustine—Diarrhoea—Ezetimibe—atherosclerosis	0.00117	0.00185	CcSEcCtD
Carmustine—Abdominal pain—Pravastatin—atherosclerosis	0.00117	0.00184	CcSEcCtD
Carmustine—Body temperature increased—Pravastatin—atherosclerosis	0.00117	0.00184	CcSEcCtD
Carmustine—Dizziness—Lovastatin—atherosclerosis	0.00115	0.00182	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—IL6—atherosclerosis	0.00115	0.00312	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.00113	0.00308	CbGpPWpGaD
Carmustine—Dizziness—Ezetimibe—atherosclerosis	0.00113	0.00179	CcSEcCtD
Carmustine—CYP1A2—Melatonin metabolism and effects—EDN1—atherosclerosis	0.00113	0.00307	CbGpPWpGaD
Carmustine—Diarrhoea—Simvastatin—atherosclerosis	0.00112	0.00176	CcSEcCtD
Carmustine—Vomiting—Lovastatin—atherosclerosis	0.00111	0.00175	CcSEcCtD
Carmustine—Hypersensitivity—Niacin—atherosclerosis	0.0011	0.00174	CcSEcCtD
Carmustine—Rash—Lovastatin—atherosclerosis	0.0011	0.00174	CcSEcCtD
Carmustine—Dermatitis—Lovastatin—atherosclerosis	0.0011	0.00174	CcSEcCtD
Carmustine—Headache—Lovastatin—atherosclerosis	0.00109	0.00173	CcSEcCtD
Carmustine—Vomiting—Ezetimibe—atherosclerosis	0.00109	0.00172	CcSEcCtD
Carmustine—Hypersensitivity—Pravastatin—atherosclerosis	0.00109	0.00172	CcSEcCtD
Carmustine—Dizziness—Simvastatin—atherosclerosis	0.00108	0.00171	CcSEcCtD
Carmustine—Rash—Ezetimibe—atherosclerosis	0.00108	0.00171	CcSEcCtD
Carmustine—Dermatitis—Ezetimibe—atherosclerosis	0.00108	0.0017	CcSEcCtD
Carmustine—Asthenia—Niacin—atherosclerosis	0.00107	0.0017	CcSEcCtD
Carmustine—Headache—Ezetimibe—atherosclerosis	0.00107	0.00169	CcSEcCtD
Carmustine—Asthenia—Pravastatin—atherosclerosis	0.00106	0.00167	CcSEcCtD
Carmustine—Vomiting—Simvastatin—atherosclerosis	0.00104	0.00164	CcSEcCtD
Carmustine—Nausea—Lovastatin—atherosclerosis	0.00104	0.00164	CcSEcCtD
Carmustine—Rash—Simvastatin—atherosclerosis	0.00103	0.00163	CcSEcCtD
Carmustine—Dermatitis—Simvastatin—atherosclerosis	0.00103	0.00162	CcSEcCtD
Carmustine—Diarrhoea—Niacin—atherosclerosis	0.00102	0.00162	CcSEcCtD
Carmustine—Headache—Simvastatin—atherosclerosis	0.00102	0.00162	CcSEcCtD
Carmustine—Nausea—Ezetimibe—atherosclerosis	0.00102	0.00161	CcSEcCtD
Carmustine—GSR—NRF2 pathway—TGFB1—atherosclerosis	0.00101	0.00276	CbGpPWpGaD
Carmustine—Diarrhoea—Pravastatin—atherosclerosis	0.00101	0.0016	CcSEcCtD
Carmustine—GSR—Metabolism—ABCG1—atherosclerosis	0.000997	0.00271	CbGpPWpGaD
Carmustine—Dizziness—Niacin—atherosclerosis	0.00099	0.00157	CcSEcCtD
Carmustine—Dizziness—Pravastatin—atherosclerosis	0.000975	0.00154	CcSEcCtD
Carmustine—Nausea—Simvastatin—atherosclerosis	0.000969	0.00153	CcSEcCtD
Carmustine—Vomiting—Niacin—atherosclerosis	0.000952	0.00151	CcSEcCtD
Carmustine—Rash—Niacin—atherosclerosis	0.000944	0.00149	CcSEcCtD
Carmustine—Dermatitis—Niacin—atherosclerosis	0.000943	0.00149	CcSEcCtD
Carmustine—Headache—Niacin—atherosclerosis	0.000938	0.00148	CcSEcCtD
Carmustine—Vomiting—Pravastatin—atherosclerosis	0.000938	0.00148	CcSEcCtD
Carmustine—GSR—Metabolism—LCAT—atherosclerosis	0.000937	0.00255	CbGpPWpGaD
Carmustine—GSR—Metabolism—FABP4—atherosclerosis	0.000937	0.00255	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—STAT3—atherosclerosis	0.000932	0.00254	CbGpPWpGaD
Carmustine—Rash—Pravastatin—atherosclerosis	0.00093	0.00147	CcSEcCtD
Carmustine—Dermatitis—Pravastatin—atherosclerosis	0.000929	0.00147	CcSEcCtD
Carmustine—Headache—Pravastatin—atherosclerosis	0.000924	0.00146	CcSEcCtD
Carmustine—GSR—Metabolism—APOA4—atherosclerosis	0.00092	0.0025	CbGpPWpGaD
Carmustine—CYP1A2—Melatonin metabolism and effects—APOE—atherosclerosis	0.000918	0.0025	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP7A1—atherosclerosis	0.000904	0.00246	CbGpPWpGaD
Carmustine—Nausea—Niacin—atherosclerosis	0.00089	0.00141	CcSEcCtD
Carmustine—Nausea—Pravastatin—atherosclerosis	0.000876	0.00138	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000852	0.00232	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CXCL8—atherosclerosis	0.000847	0.0023	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP27A1—atherosclerosis	0.000835	0.00227	CbGpPWpGaD
Carmustine—GSR—Metabolism—PLA2G2A—atherosclerosis	0.000792	0.00215	CbGpPWpGaD
Carmustine—GSR—Metabolism—APOA2—atherosclerosis	0.000792	0.00215	CbGpPWpGaD
Carmustine—GSR—Metabolism—ALOX15—atherosclerosis	0.000792	0.00215	CbGpPWpGaD
Carmustine—GSR—Metabolism—ALOX5AP—atherosclerosis	0.000792	0.00215	CbGpPWpGaD
Carmustine—GSR—Metabolism—ABCG5—atherosclerosis	0.000782	0.00213	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—NFKB1—atherosclerosis	0.000758	0.00206	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—LPL—atherosclerosis	0.000757	0.00206	CbGpPWpGaD
Carmustine—GSR—Metabolism—LPA—atherosclerosis	0.000755	0.00206	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MAPK8—atherosclerosis	0.000745	0.00203	CbGpPWpGaD
Carmustine—GSR—Metabolism—BGN—atherosclerosis	0.000732	0.00199	CbGpPWpGaD
Carmustine—GSR—Metabolism—APOA5—atherosclerosis	0.000724	0.00197	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CD36—atherosclerosis	0.000719	0.00196	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000704	0.00192	CbGpPWpGaD
Carmustine—GSR—Metabolism—PLA2G1B—atherosclerosis	0.000697	0.0019	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—GPX1—atherosclerosis	0.000691	0.00188	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—VEGFA—atherosclerosis	0.000688	0.00187	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—STAT3—atherosclerosis	0.000681	0.00185	CbGpPWpGaD
Carmustine—GSR—Metabolism—ALOX5—atherosclerosis	0.000673	0.00183	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MAPK3—atherosclerosis	0.000651	0.00177	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP7A1—atherosclerosis	0.00065	0.00177	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000641	0.00175	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—atherosclerosis	0.000606	0.00165	CbGpPWpGaD
Carmustine—GSR—Metabolism—NAMPT—atherosclerosis	0.000604	0.00164	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP27A1—atherosclerosis	0.000601	0.00164	CbGpPWpGaD
Carmustine—GSR—Metabolism—LIPC—atherosclerosis	0.0006	0.00163	CbGpPWpGaD
Carmustine—GSR—Metabolism—APOC3—atherosclerosis	0.000596	0.00162	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000593	0.00161	CbGpPWpGaD
Carmustine—GSR—Metabolism—LDLR—atherosclerosis	0.000593	0.00161	CbGpPWpGaD
Carmustine—GSR—Metabolism—CETP—atherosclerosis	0.000579	0.00158	CbGpPWpGaD
Carmustine—GSR—Metabolism—SCARB1—atherosclerosis	0.000554	0.00151	CbGpPWpGaD
Carmustine—CYP1A2—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.000546	0.00148	CbGpPWpGaD
Carmustine—GSR—Metabolism—HMGCR—atherosclerosis	0.000524	0.00142	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—IL6—atherosclerosis	0.000476	0.00129	CbGpPWpGaD
Carmustine—GSR—Metabolism—ABCA1—atherosclerosis	0.000467	0.00127	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—GSTM1—atherosclerosis	0.000459	0.00125	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.000453	0.00123	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	0.000435	0.00118	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000427	0.00116	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.000407	0.00111	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.000404	0.0011	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000402	0.00109	CbGpPWpGaD
Carmustine—GSR—Metabolism—HMOX1—atherosclerosis	0.0004	0.00109	CbGpPWpGaD
Carmustine—GSR—Metabolism—APOB—atherosclerosis	0.000384	0.00104	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000377	0.00103	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTM1—atherosclerosis	0.000373	0.00102	CbGpPWpGaD
Carmustine—GSR—Metabolism—LPL—atherosclerosis	0.000366	0.000996	CbGpPWpGaD
Carmustine—GSR—Metabolism—GPX1—atherosclerosis	0.000357	0.000972	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000348	0.000948	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000348	0.000948	CbGpPWpGaD
Carmustine—GSR—Metabolism—CD36—atherosclerosis	0.000348	0.000947	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000342	0.000932	CbGpPWpGaD
Carmustine—GSR—Metabolism—MTHFR—atherosclerosis	0.00033	0.000897	CbGpPWpGaD
Carmustine—GSR—Metabolism—PPARA—atherosclerosis	0.000323	0.00088	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.000314	0.000855	CbGpPWpGaD
Carmustine—GSR—Metabolism—AGT—atherosclerosis	0.000313	0.000852	CbGpPWpGaD
Carmustine—GSR—Metabolism—APOE—atherosclerosis	0.000307	0.000835	CbGpPWpGaD
Carmustine—GSR—Metabolism—CAV1—atherosclerosis	0.000304	0.000827	CbGpPWpGaD
Carmustine—GSR—Metabolism—APOA1—atherosclerosis	0.000303	0.000826	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000294	0.000799	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.000294	0.000799	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CG—atherosclerosis	0.000277	0.000754	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000275	0.000749	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	0.000269	0.000731	CbGpPWpGaD
Carmustine—GSR—Metabolism—PPARG—atherosclerosis	0.000267	0.000727	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	0.000265	0.00072	CbGpPWpGaD
Carmustine—GSR—Metabolism—INS—atherosclerosis	0.000262	0.000713	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000259	0.000705	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000259	0.000705	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000254	0.000692	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.00025	0.000679	CbGpPWpGaD
Carmustine—GSR—Metabolism—ALB—atherosclerosis	0.00024	0.000654	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000231	0.000628	CbGpPWpGaD
Carmustine—GSR—Metabolism—NOS3—atherosclerosis	0.00023	0.000626	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000219	0.000595	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000219	0.000595	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000219	0.000595	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000219	0.000595	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000216	0.000588	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTGS2—atherosclerosis	0.00021	0.000572	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000209	0.000568	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.0002	0.000545	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000193	0.000524	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	0.00019	0.000518	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000186	0.000506	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PLTP—atherosclerosis	0.000179	0.000487	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000166	0.000451	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000165	0.000448	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000164	0.000446	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.00016	0.000435	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCG8—atherosclerosis	0.000155	0.000422	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LTA4H—atherosclerosis	0.000155	0.000422	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000153	0.000417	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000145	0.000394	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000129	0.000351	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCG1—atherosclerosis	0.000123	0.000334	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—FABP4—atherosclerosis	0.000115	0.000314	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LCAT—atherosclerosis	0.000115	0.000314	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—APOA4—atherosclerosis	0.000113	0.000308	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP7A1—atherosclerosis	0.000111	0.000303	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000106	0.000288	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKT1—atherosclerosis	0.000106	0.000288	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	0.000103	0.00028	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000101	0.000275	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	9.87e-05	0.000269	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	9.75e-05	0.000265	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALOX15—atherosclerosis	9.75e-05	0.000265	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	9.75e-05	0.000265	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—APOA2—atherosclerosis	9.75e-05	0.000265	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCG5—atherosclerosis	9.63e-05	0.000262	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	9.62e-05	0.000262	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LPA—atherosclerosis	9.3e-05	0.000253	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—BGN—atherosclerosis	9e-05	0.000245	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	8.94e-05	0.000243	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—APOA5—atherosclerosis	8.91e-05	0.000243	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.66e-05	0.000236	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	8.58e-05	0.000233	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.48e-05	0.000231	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	8.41e-05	0.000229	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	8.39e-05	0.000228	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALOX5—atherosclerosis	8.29e-05	0.000225	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.66e-05	0.000208	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NAMPT—atherosclerosis	7.43e-05	0.000202	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.39e-05	0.000201	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LIPC—atherosclerosis	7.39e-05	0.000201	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—APOC3—atherosclerosis	7.34e-05	0.0002	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LDLR—atherosclerosis	7.3e-05	0.000198	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CETP—atherosclerosis	7.13e-05	0.000194	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SCARB1—atherosclerosis	6.82e-05	0.000186	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.64e-05	0.000181	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HMGCR—atherosclerosis	6.44e-05	0.000175	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.81e-05	0.000158	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCA1—atherosclerosis	5.74e-05	0.000156	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HMOX1—atherosclerosis	4.93e-05	0.000134	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—APOB—atherosclerosis	4.72e-05	0.000128	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTM1—atherosclerosis	4.59e-05	0.000125	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LPL—atherosclerosis	4.51e-05	0.000123	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GPX1—atherosclerosis	4.4e-05	0.00012	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CD36—atherosclerosis	4.28e-05	0.000117	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MTHFR—atherosclerosis	4.06e-05	0.00011	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPARA—atherosclerosis	3.98e-05	0.000108	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AGT—atherosclerosis	3.86e-05	0.000105	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—APOE—atherosclerosis	3.78e-05	0.000103	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CAV1—atherosclerosis	3.74e-05	0.000102	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—APOA1—atherosclerosis	3.73e-05	0.000102	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	3.41e-05	9.28e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPARG—atherosclerosis	3.29e-05	8.95e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—INS—atherosclerosis	3.23e-05	8.78e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALB—atherosclerosis	2.96e-05	8.05e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NOS3—atherosclerosis	2.83e-05	7.7e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.59e-05	7.04e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.3e-05	3.54e-05	CbGpPWpGaD
